Supporting transformational science

Focused, committed and patient

Syncona announced Full Year Results on the 6th July

Click here to review the materials

Results Centre

Welcome to Syncona

Syncona is a leading FTSE250 company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating attractive returns for shareholders.

We are aligned with two of the premium charitable funders in life science, the Wellcome Trust, original founder of Syncona’s life science division, and Cancer Research UK both of which are significant shareholders in Syncona.  We are listed on the London Stock Exchange under the ticker SYNC.


About Syncona

Learn More +

Our People

Learn More +

Our Portfolio

Learn More +

Investor Relations

Learn More +